- Country: USA
- Summary: Notice of Intent Replacement Cell Separators
- UST Ref No: 99203420
- Deadline: 05 Apr 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 24-006121
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Notice of Intent Blood Services Section, TerumoBCT Spectra Optia Blood
Cell Separators Purchase
Product Service Code: 6515 - Medical and Surgical Instruments, Equipment, and Supplies NAICS Code: 339112 - (Not Small Business Size Standards- 1,250 Average Number of Employees) Place of Performance: Bethesda, MD 20892 USA
POTS: 24-006121
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The Department of Transfusion Medicine (DTM) serves as the clinical laboratory of the National Institutes of Health (NIH). Clinical Center. Provide high quality patient care and hospital services in support of NIH clinical research programs, to pursue research that contributes to our knowledge and practice of transfusion medicine and related technologies, and to provide advanced training in transfusion medicine. Together these programs promote the basic goals of the Clinical Center. The NIH and DHHS: that is, to enhance the health and well-being of Americans.
The purpose of this requirement is to acquire two new automated blood cells
Separators, 2 61000 Spectra Optia Apheresis System
The recommended service life for the Optia is 10 years. Our oldest Spectra Optias were purchased in 2013. There are certain components in the older instruments which have become obsolete and unavailable from service suppliers.
Terumo BCT, Colorado 80215-4440 is uniquely qualified to replace the existing Spectra Optia Apheresis System. Terumo BCT T is the sole source manufacture of the Spectra Optia and is the only known distributor of the compatible equipment. There are devices on the market that perform one or a mix of these collections, but the TerumoBCT Spectra Optia System is the only device on the market that does all these activities on the same platform. The recommended service life for the Optia is 10 years. Ext... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNotice of Intent Replacement Cell Separators - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Notice of Intent Replacement Cell Separators. This tender is published on USARFP under UST Ref No: 99203420 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
